tert-Butyl cis-3-amino-5-fluoropiperidine-1-carboxylate

Catalog No. :
ACKBMY953
CAS No. :
1955555-01-7
Molecular Formula :
C10H19FN2O2
Molecular Weight :
218.27

IUPAC Name:tert-butyl (3R,5S)-3-amino-5-fluoropiperidine-1-carboxylate

tert-Butyl cis-3-amino-5-fluoropiperidine-1-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg95%$443.00Login to see priceInquiryInquiry
100mg95%$650.00Login to see priceInquiryInquiry
250mg95%$921.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-Butyl cis-3-amino-5-fluoropiperidine-1-carboxylate
IUPAC Nametert-butyl (3R,5S)-3-amino-5-fluoropiperidine-1-carboxylate
MDL No.MFCD30012449
Molecular FormulaC10H19FN2O2
Molecular Weight218.27
SMILESO=C(N1C[C@H](N)C[C@H](F)C1)OC(C)(C)C
InChI KeyQHVIBSNJHHGNCZ-JGVFFNPUSA-N
Synonymrac-tert-butyl (3R,5S)-3-amino-5-fluoropiperidine-1-carboxylate;cis-3-Amino-5-fluoro-piperidine-1-carboxylic acid tert-butyl ester;rel-tert-Butyl (3R,5S)-3-amino-5-fluoropiperidine-1-carboxylate;(3S,5R)-tert-butyl 3-amino-5-fluoropiperidine-1-carboxylate;1-Piperidinecarboxylic acid, 3-amino-5-fluoro-, 1,1-dimethylethyl ester, (3R,5S)-rel-
CAS No.1955555-01-7

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H315-H319
Precautionary Statement(s)
P264-P280-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362+P364

Synthetic Route by SureRoute

1. ACKBMY953 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACKBMY953 route product structure diagram
    ACKBMY9531955555-01-7
Inquiry

2. ACKBMY953 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACKBMY953 route product structure diagram
    ACKBMY9531955555-01-7
Inquiry

Comments (0)